| Basic RNAi, siRNA and Gene Silencing Mechanisms | |
| RNAi beginnings: overview of the pathway in C. elegans | |
| Dicer in RNAi: its roles in vivo and utility in vitro | |
| Genes required for RNAi | |
| MicroRNAs: a small contribution from worms | |
| miRNAs in the brain and the application of RNAi to neurons; | |
| Design and Synthesis of siRNAs | |
| Design and synthesis of small interfering RNA (siRNA) | |
| Automated design and high throughput synthesis of siRNA | |
| Rational design of siRNAs with the Sfold software | |
| Enzymatic production of siRNAS; | |
| Vector Development and In Vivo, In Vitro and In Ovo Delivery Methods | |
| Six methods of inducing RNAi in mammalian cells | |
| Viral delivery of siRNA | |
| siRNA delivery by lentiviral vectors: design and applications | |
| Liposomal delivery of siRNAs in mice | |
| Chemical modifications to achieve increased stability and sensitive detection of siRNA | |
| RNAi in postimplantation mouse embryos | |
| In ovo RNAi opens new possibilities for functional genomics in vertebrates; | |
| Gene Silencing in Model Organisms | |
| Practical applications of RNAi in C. elegans | |
| Inducible RNAi as a forward genetic tool in Trypanosoma brucei | |
| RNAi gene silencing in yeast | |
| RNA silencing in filamentous fungi: Mucor circinelloides as a model organism | |
| RNAi and gene silencing phenomenon mediated by viral suppressors in plants; | |
| Drug Target Validation | |
| Delivering siRNA in vivo for functional genomics and novel therapeutics | |
| The role of RNAi in drug target validation: application to Hepatitis C | |
| RNAi in the drug discovery process | |
| RNAi: use in the drug discovery process; | |
| Therapeutic and Drug Development | |
| RNAi-mediated silencing of viral gene expression and replication | |
| RNAi in drug development: practical considerations | |
| RNAi for the treatment of liver diseases | |
| RNAi applications in animal systems; | |
| Genome Wide RNAi and High Through-Put Analysis | |
| High through-put RNAi-by-soaking in Caenorhabditis elegans | |
| Tools for integrative genomics: genome-Wide RNAi and expression profiling in Drosophila | |
| Microarray analysis and RNA silencing to determine genes functionally important in Mesothelioma | |
| High through-put RNAi | |
| Generation of highly specific vector-based shRNAi libraries directed against the entire human genome | |
| Table of Contents provided by Publisher. All Rights Reserved. |